Navigation Links
2007 InfantSEE(R) Data Magnifies the Need for Early Eye and Vision Screenings for Infants, According to American Optometric Association
Date:10/26/2007

uce the threat of serious vision impairments. In fact, one in every 10 children is at risk from undiagnosed eye and vision problems.

InfantSEE(R) assessments are complementary to the routine well-care exams a baby receives from a pediatrician or family physician. Infants have long received eye screenings for strabismus and leukocoria from their trusted pediatricians as part of a full well-care check-up to detect a host of large- scope health problems. Many cases of successful intervention have resulted from this process. However, optometrists have the time to perform a comprehensive eye and vision assessment, the instrumentation to identify areas of risk that are critical to a child's vision development and the skills to identify conditions that might not be detected in a routine pediatric wellness exam and that may need to be monitored, immediately treated or referred to a pediatric eye specialist. InfantSEE(R) aims to detect more subtle problems earlier, so infants can be managed by optometrists, ophthalmologists or other medical specialists as necessary.

Although infants cannot respond verbally, the first year of life is an ideal time to conduct an extensive eye assessment. Not only is this a critical time for eye and vision development, but generally children at this age do not yet fear doctor visits and find the assessment painless and often enjoyable. Typically, infants sit on their parent's lap during the assessment, in which the optometrist uses lights and other hand-held objects to check that their eyes are working together and that there are no significant refractive or health issues that will impede proper vision development.

To learn more about InfantSEE(R), visit http://www.InfantSEE.org.

About the American Optometric Association

American Optometric Association doctors of optometry are highly qualified, trained doctors, on the frontline of eye health and vision care, who
'/>"/>

SOURCE American Optometric Association
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Gene linked to early puberty in girls
2. Cancer drugs in development nearly doubled since 1995
3. Nearly all asthma deaths preventable
4. Ductal lavage may detect early breast cancer
5. Doctors advice early anemia tests
6. Heart disease threat starts early in life for Diabetics
7. Early detection of prostate cancer
8. Early detection of heart attack
9. Early puberty linked to nutrition
10. Exercise to Prevent Early Breast Cancer
11. Drug Found To Bring Relief For Individuals With Early Parkinson’

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...6 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. (... will report financial results for the third quart...ay, November 9, 2009. Cardiome will hold a telecon... Pacific) on that day to discuss the results. ,, T...7806 or 888-789-9572 and reference conference 2345...
(Date:11/6/2009)... & Lymphoma Society (LLS) will again be partic...h in its first two campaigns this past spring and ...LS,s blood cancer research funding and patient edu...n, taking place from November 12th to 15th, Gap In... participants can use (in-store only) at all Gap ...
(Date:11/6/2009)... urgent message to the U.S. House of Representativ... in debate over procedures related to abortion and...eting to discuss proposed amendments to the bill, ... permit discussion of "an amendment to keep in pla...science protections." Some in the House seek a "cl...
(Date:11/6/2009)...rganizations specializing in infectious diseases p... expressing their significant concern with current...rotective equipment (PPE) by healthcare workers in...1 influenza. The Society for Healthcare Epidemio...ciety of America (IDSA) and the Association for Pr...
(Date:11/6/2009)...o by, researcher says , , FRIDAY, Nov. 6 (...le with multiple sclerosis who have relapses withi...kely to suffer from severe limitations in the shor...ngs, published Nov. 4 in Neurology , show that pe...s of developing it are nearly 50 percent more like...
Breaking Medicine News(10 mins):Health News:Cardiome to Release Third Quarter Results 2Health News:Cardiome to Release Third Quarter Results 3Health News:Get a Jump on Your Holiday Shopping and Give Two Gifts This Season: One to Your Loved Ones and One to People Battling Blood Cancer 2Health News:Bishops to House: Keep Abortion Funding Out of Health Care Reform, Make Health Care Available to Vulnerable 2Health News:Bishops to House: Keep Abortion Funding Out of Health Care Reform, Make Health Care Available to Vulnerable 3Health News:Bishops to House: Keep Abortion Funding Out of Health Care Reform, Make Health Care Available to Vulnerable 4Health News:Bishops to House: Keep Abortion Funding Out of Health Care Reform, Make Health Care Available to Vulnerable 5Health News:Prevention experts urge modification to 2009 H1N1 guidance for health care workers 2Health News:Early Relapse of MS May Mean Fewer Issues Later 2
...th Staphylococcal,HIV, Tuberculosis and Other Infe...pitalized,patients for drug-resistant infections c...educe cost of care, according to a new report rele...,physicians to adjust medications or take other st...
...rgest Hope Lodge in,New York City, NEW YORK, Marc...enges. Finding an affordable, supportive place to ...ancer Society is pleased to,announce its newest an...t., the Hope Lodge,in Manhattan meets an urgent, p...
...r shamans and herb women? Not at all, for many che...cine are natural products or were developed on the...n prostate and breast cancer treatment are made fr... example, against malignant lymphomas. The modern ...
...on Against This Leading Cause...ording to the national,nonprofit, Home Safety Coun...use of home injury death in the United States. Yet...home safety concern,proving the need for aggressiv...
...hairman and Chief Executive Officer of Met-Pro Cor...pany,s Systems Division has received an,order to s... to a major,pharmaceutical company in the Northeas...the Company,s current fiscal,year., Working with ...
...ol? You may want to schedule a few appointments wi...e about how to shape up your eating habits, accord...ichigan Health System researchers. , Not only ar...e already taking one. And youll probably lose weig...
Other Medicine News:Health News:Hospital Testing for Drug-Resistant Infections Dramatically Lowers Mortality Rates and Costs 2Health News:American Cancer Society to Open Doors to Its New Free Lodging and Support Center in NYC for Cancer Patients and Caregivers 2Health News:Screening the herbal pharmacy 2Health News:New Home Safety Council(R) Research Shows the Majority of Families Underestimate the Danger of Poisoning Exposure at Home 2Health News:New Home Safety Council(R) Research Shows the Majority of Families Underestimate the Danger of Poisoning Exposure at Home 3Health News:New Home Safety Council(R) Research Shows the Majority of Families Underestimate the Danger of Poisoning Exposure at Home 4Health News:Met-Pro Corporation's Systems Division Receives Equipment Order Totaling Approximately $600,000 2Health News:Met-Pro Corporation's Systems Division Receives Equipment Order Totaling Approximately $600,000 3Health News:Study shows cholesterol-lowering power of dietitian visits 2Health News:Study shows cholesterol-lowering power of dietitian visits 3Health News:Study shows cholesterol-lowering power of dietitian visits 4
(Date:11/6/2009)...ewswire/ -- NexBio Inc., in collaboration with sci...vention (CDC), St. Louis University, and the Unive...n of two articles in the peer-reviewed journal PLo...AS181 (Fludase ® ) may play a potentially imp...e Pandemic Influenza A(H1N1) and drug-resistant in...
(Date:11/5/2009)...5 Osteotech, Inc. (Nasda...ogic products for regenerative healing, today repo... September 30, 2009. ,, "During the third quart...ree new biologic products MagniFuse(TM) Bone Graf...74; Innovative Grafting," said Sam Owusu-Akyaw, Pr...
(Date:11/5/2009)...PRNewswire/ -- ARKRAY, Inc., the world,s 5th large...s, today announced that it has received 510(k) cle...r its new GLUCOCARD Vital blood glucose monitoring...hich ARKRAY will make available for distribution i...complement to the existing GLUCOCARD line of produ...
Breaking Medicine Technology:NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 2NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 3NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 4Osteotech Reports Third Quarter 2009 Financial Results 2Osteotech Reports Third Quarter 2009 Financial Results 3Osteotech Reports Third Quarter 2009 Financial Results 4Osteotech Reports Third Quarter 2009 Financial Results 5Osteotech Reports Third Quarter 2009 Financial Results 6Osteotech Reports Third Quarter 2009 Financial Results 7Osteotech Reports Third Quarter 2009 Financial Results 8ARKRAY, Inc. Receives FDA Clearance for New GLUCOCARD(R) Vital(TM) Blood Glucose Monitoring System 2Comparative Effectiveness Research Study in Mayo Clinic Proceedings Demonstrated Asthma Patients Had Better Overall Results with Oral Controllers than 55398 1Comparative Effectiveness Research Study in Mayo Clinic Proceedings Demonstrated Asthma Patients Had Better Overall Results with Oral Controllers than 55398 2Comparative Effectiveness Research Study in Mayo Clinic Proceedings Demonstrated Asthma Patients Had Better Overall Results with Oral Controllers than 55398 3Comparative Effectiveness Research Study in Mayo Clinic Proceedings Demonstrated Asthma Patients Had Better Overall Results with Oral Controllers than 55398 4Medical Arts Radiology Chooses Optimum Lightpath to Speed Anytime Anywhere Access to Patient Data and Communications 55393 1Medical Arts Radiology Chooses Optimum Lightpath to Speed Anytime Anywhere Access to Patient Data and Communications 55393 2Medical Arts Radiology Chooses Optimum Lightpath to Speed Anytime Anywhere Access to Patient Data and Communications 55393 3Endo Pharmaceuticals to Partner With ProStrakan to Commercialize FORTESTA 28TM 29 in the U S 55388 1Endo Pharmaceuticals to Partner With ProStrakan to Commercialize FORTESTA 28TM 29 in the U S 55388 2Endo Pharmaceuticals to Partner With ProStrakan to Commercialize FORTESTA 28TM 29 in the U S 55388 3Endo Pharmaceuticals to Partner With ProStrakan to Commercialize FORTESTA 28TM 29 in the U S 55388 4
... FOR RELEASE AT 5 P.M. EDT MONDAY, AUG. 4/, /ADVA...r should not be,screened for prostate cancer, and ...of the prostate-specific antigen (PSA) test with t...a new recommendation from the U.S.,Preventive Serv...ng,evidence summary appear in the August 5 issue o...
...nts achieved SVR 12 with 48-week boceprevir-based ... High SVR 24 rate also reported for 28-week bocepr...gh,Corporation (NYSE: SGP ) today reported top-li...ase II study of boceprevir, its investigational,or...owed a high rate of,sustained virologic response (...
Other Medicine Technology:Task Force Says Men Age 75 and Older Should Not Be Screened For Prostate Cancer 2Task Force Says Men Age 75 and Older Should Not Be Screened For Prostate Cancer 3Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 2Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 3Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 4Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 5Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 6Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 7Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 8Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 9
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
Medicine Products: